G211-0217 Screening compound: 2-cyclohexyl-3-oxo-N-(1,3-thiazol-2-yl)-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

G211-0217 Screening compound: 2-cyclohexyl-3-oxo-N-(1,3-thiazol-2-yl)-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide
G211-0217 Screening compound: 2-cyclohexyl-3-oxo-N-(1,3-thiazol-2-yl)-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G211-0217
2-cyclohexyl-3-oxo-N-(1,3-thiazol-2-yl)-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G211-0217

Molecular Formula

C21H20N4O2S (C21 H20 N4 O2 S)

Compound Name

2-cyclohexyl-3-oxo-N-(1,3-thiazol-2-yl)-1H,2H,3H-pyrrolo[3,4-b]quinoline-9-carboxamide

IUPAC name

2-cyclohexyl-3-oxo-N-(13-thiazol-2-yl)-1H2H3H-pyrrolo[34-b]quinoline-9-carboxamide

SMILES

O=C(c1c(CN(C2CCCCC2)C2=O)c2nc2ccccc12)Nc1nccs1

InChI

InChI=1S/C21H20N4O2S/c26-19(24-21-22-10-11-28-21)17-14-8-4-5-9-16(14)23-18-15(17)12-25(20(18)27)13-6-2-1-3-7-13/h4-5,8-11,13H,1-3,6-7,12H2,(H,22,24,26)

InChI Key

QHRFFCLOBILUHU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27210914

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

392.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.083

Distribution Coefficient, logD

4.021

Water Solubility, LogSw

-4.44

Polar Surface Area

59.034

Acid Dissociation Constant (pKa)

8.22

Base Dissociation Constant (pKb)

1.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

G211-0217 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Targeted Diversity Library (40567 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with G211-0217 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G211-0217?
Check Price and Availability of G211-0217, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G211-0217 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G211-0217
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G211-0217
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G211-0217 available by request